Abstract
Summary
The global Healthcare Contract Development and Manufacturing Organization Market accrued earnings worth approximately 207.2 (USD Billion) in 2020 and is predicted to gain revenue of about 390.1 (USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028. The report offers assessment and analysis of the Healthcare Contract Development and Manufacturing Organization Market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion). Healthcare Contract Development And Manufacturing Organization Market: Outlook
Healthcare Contract Development and Manufacturing Organization provide a slew of services on contractual basis ranging from drug production to new drug launches in pharmaceutical sector. It assists firms in outsourcing required business operations that require external aid, as well as enhanced scalability of firms. The firm offers services such as formal stability, batch registration, commercial production, clinical trials, method development, and formulation pre-formulation development. A key aim of healthcare contract development and manufacturing firms is to promote end-to-end efficacy of business operations and provide seamless solutions to clients.
Healthcare Contract Development And Manufacturing Organization Market: Growth Factors
Expansion of healthcare contract development and manufacturing organization industry in next seven years can be ascribed to surge in outsourcing activities by pharmaceutical firms high funding in research development programs. In addition to this, medical devices are also contributing sizably towards growth of healthcare contract development and manufacturing organization business. Apparently, rise in end-to-end service providers offering value added solutions for risk sharing business model will upswing industry expansion. Industry participants are offering biotech pharmaceutical solutions at cost-effective rates, saving time of customers.
Furthermore, rise in medical equipment in developing economies and surge in number of firms focusing on research development activities will drive market trends. Surge in efficiency of CDMO firms are set to contribute lucratively towards market size. Escalating need for enhancing quality assurance solutions will prop up expansion of healthcare contract development and manufacturing organization industry. New product launches are slated to influence business space.
Report Scope:
Healthcare Contract Development And Manufacturing Organization Market: Regional Landscape
North American Market To Retain Dominant Status Over Forecast Timespan
Expansion of regional market over assessment period can be due to easy availability of healthcare infrastructure facility and availing of outsourcing services at lesser costs. In addition to this, massive need of medical equipment will translate into regional market growth. Furthermore, a thriving pharmaceutical sector in countries such as the U.S. will contribute significantly towards regional market proceeds.
Competitive Insights
Key players influencing market growth and profiled in report are Covance Inc., Sanmina Corporation, Thermo Fisher Scientific Inc., Jabil Inc., Lonza Group Ltd., Siegfried Holding AG, Recipharm AB, Flex Ltd., IQVIA Holdings Inc., and Catalent Inc.
The global Healthcare Contract Development and Manufacturing Organization Market is segmented as follows:
By Services
Contract Manufacturing
Contract Development
By Region
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East Africa
GCC
South Africa
Rest of Middle East Africa
Table of Contents
1 Preface
1.1 Report Description and Scope
1.2 Research scope
1.3 Research methodology
1.3.1 Market Research Type
1.3.2 Market research methodology
2 Executive Summary
2.1 Global Healthcare Contract Development and Manufacturing Organization Market, (2022 - 2028) (USD Billion)
2.2 Global Healthcare Contract Development and Manufacturing Organization Market : snapshot
3 Global Healthcare Contract Development and Manufacturing Organization Market - Industry Analysis
3.1 Healthcare Contract Development and Manufacturing Organization Market: Market Dynamics
3.2 Market Drivers
3.3 Market Restraints
3.4 Market Opportunities
3.5 Market Challenges
3.6 Porter’s Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market attractiveness analysis By Services
4 Global Healthcare Contract Development and Manufacturing Organization Market- Competitive Landscape
4.1 Company market share analysis
4.1.1 Global Healthcare Contract Development and Manufacturing Organization Market: company market share, 2021
4.2 Strategic development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, cullaborations, and joint ventures
4.2.4 Research and development and Regional expansion
4.3 Price trend analysis
5 Global Healthcare Contract Development and Manufacturing Organization Market - Services Analysis
5.1 Global Healthcare Contract Development and Manufacturing Organization Market overview: By Services
5.1.1 Global Healthcare Contract Development and Manufacturing Organization Market share, By Services, 2021 and 2028
5.2 Contract Manufacturing
5.2.1 Global Healthcare Contract Development and Manufacturing Organization Market by Contract Manufacturing, 2022 - 2028 (USD Billion)
5.3 Contract Development
5.3.1 Global Healthcare Contract Development and Manufacturing Organization Market by Contract Development, 2022 - 2028 (USD Billion)
6 Healthcare Contract Development and Manufacturing Organization Market - Regional Analysis
6.1 Global Healthcare Contract Development and Manufacturing Organization Market Regional Overview
6.2 Global Healthcare Contract Development and Manufacturing Organization Market Share, by Region, 2021 & 2028 (USD Billion)
6.3 North America
6.3.1 North America Healthcare Contract Development and Manufacturing Organization Market, 2022 - 2028 (USD Billion)
- 6.3.1.1 North America Healthcare Contract Development and Manufacturing Organization Market, by Country, 2022 - 2028 (USD Billion)
6.4 North America Healthcare Contract Development and Manufacturing Organization Market, by Services, 2022 - 2028
6.4.1 North America Healthcare Contract Development and Manufacturing Organization Market, by Services, 2022 - 2028 (USD Billion)
6.4.2 Europe Healthcare Contract Development and Manufacturing Organization Market, 2022 - 2028 (USD Billion)
- 6.4.2.1 Europe Healthcare Contract Development and Manufacturing Organization Market, by Country, 2022 - 2028 (USD Billion)
6.5 Asia Pacific
6.5.3 Asia Pacific Healthcare Contract Development and Manufacturing Organization Market, 2022 - 2028 (USD Billion)
- 6.5.3.1 Asia Pacific Healthcare Contract Development and Manufacturing Organization Market, by Country, 2022 - 2028 (USD Billion)
6.6 Latin America
6.6.4 Latin America Healthcare Contract Development and Manufacturing Organization Market, 2022 - 2028 (USD Billion)
- 6.6.4.1 Latin America Healthcare Contract Development and Manufacturing Organization Market, by Country, 2022 - 2028 (USD Billion)
6.7 The Middle-East and Africa
6.7.5 The Middle-East and Africa Healthcare Contract Development and Manufacturing Organization Market, 2022 - 2028 (USD Billion)
- 6.7.5.1 The Middle-East and Africa Healthcare Contract Development and Manufacturing Organization Market, by Country, 2022 - 2028 (USD Billion)
7 Company Profiles
7.1 Covance Inc
7.1.1 Overview
7.1.2 Financials
7.1.3 Product Portfolio
7.1.4 Business Strategy
7.1.5 Recent Developments
7.2 Sanmina Corporation
7.2.1 Overview
7.2.2 Financials
7.2.3 Product Portfolio
7.2.4 Business Strategy
7.2.5 Recent Developments
7.3 Thermo Fisher Scientific Inc
7.3.1 Overview
7.3.2 Financials
7.3.3 Product Portfolio
7.3.4 Business Strategy
7.3.5 Recent Developments
7.4 Jabil Inc
7.4.1 Overview
7.4.2 Financials
7.4.3 Product Portfolio
7.4.4 Business Strategy
7.4.5 Recent Developments
7.5 Lonza Group Ltd
7.5.1 Overview
7.5.2 Financials
7.5.3 Product Portfolio
7.5.4 Business Strategy
7.5.5 Recent Developments
7.6 Siegfried Holding AG
7.6.1 Overview
7.6.2 Financials
7.6.3 Product Portfolio
7.6.4 Business Strategy
7.6.5 Recent Developments
7.7 Recipharm AB
7.7.1 Overview
7.7.2 Financials
7.7.3 Product Portfolio
7.7.4 Business Strategy
7.7.5 Recent Developments
7.8 Flex Ltd
7.8.1 Overview
7.8.2 Financials
7.8.3 Product Portfolio
7.8.4 Business Strategy
7.8.5 Recent Developments
7.9 IQVIA Holdings Inc
7.9.1 Overview
7.9.2 Financials
7.9.3 Product Portfolio
7.9.4 Business Strategy
7.9.5 Recent Developments
7.10 Catalent Inc
7.10.1 Overview
7.10.2 Financials
7.10.3 Product Portfolio
7.10.4 Business Strategy
7.10.5 Recent Developments